AAREYDRUGS Stock Overview
Manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aarey Drugs & Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹55.00 |
| 52 Week High | ₹74.80 |
| 52 Week Low | ₹37.35 |
| Beta | 0.92 |
| 11 Month Change | -5.64% |
| 3 Month Change | -10.41% |
| 1 Year Change | 12.59% |
| 33 Year Change | 58.27% |
| 5 Year Change | n/a |
| Change since IPO | 26.87% |
Recent News & Updates
Recent updates
Earnings Not Telling The Story For Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) After Shares Rise 46%
Aug 30
Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) Shares May Have Run Too Fast Too Soon
Jul 16Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Apr 15Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet
Mar 22What Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) P/E Is Not Telling You
Dec 30Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 29Calculating The Fair Value Of Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
Aug 20Shareholder Returns
| AAREYDRUGS | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.2% | 0.5% | 0.5% |
| 1Y | 12.6% | 42.5% | 27.5% |
Return vs Industry: AAREYDRUGS underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: AAREYDRUGS underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| AAREYDRUGS volatility | |
|---|---|
| AAREYDRUGS Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: AAREYDRUGS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: AAREYDRUGS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Mihir Ghatalia | www.aareydrugs.com |
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals.
Aarey Drugs & Pharmaceuticals Limited Fundamentals Summary
| AAREYDRUGS fundamental statistics | |
|---|---|
| Market cap | ₹1.62b |
| Earnings (TTM) | ₹60.10m |
| Revenue (TTM) | ₹5.19b |
26.0x
P/E Ratio0.3x
P/S RatioIs AAREYDRUGS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AAREYDRUGS income statement (TTM) | |
|---|---|
| Revenue | ₹5.19b |
| Cost of Revenue | ₹5.01b |
| Gross Profit | ₹176.24m |
| Other Expenses | ₹116.14m |
| Earnings | ₹60.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 2.12 |
| Gross Margin | 3.40% |
| Net Profit Margin | 1.16% |
| Debt/Equity Ratio | 28.5% |
How did AAREYDRUGS perform over the long term?
See historical performance and comparison